User profiles for Edward P. Stern

Edward Stern

Clinical Research Fellow, UCL
Verified email at ucl.ac.uk
Cited by 566

The pathogenesis of systemic sclerosis

EP Stern, CP Denton - Rheumatic Disease Clinics, 2015 - rheumatic.theclinics.com
Systemic sclerosis (SSc; also called scleroderma) is a complex multisystem disorder with
heterogeneous clinical features. The disease is broadly divided by clinical phenotypes, which …

UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis

BM Lynch, EP Stern, V Ong, M Harber… - Clinical and …, 2016 - discovery.ucl.ac.uk
The UK Scleroderma Study Group developed guidelines on the diagnosis and management
of scleroderma renal crisis (SRC) based on best available evidence and clinical experience…

[HTML][HTML] Urine YKL-40 is associated with progressive acute kidney injury or death in hospitalized patients

IE Hall, EP Stern, LG Cantley, JA Elias, CR Parikh - BMC nephrology, 2014 - Springer
Background A translational study in renal transplantation suggested YKL-40, a chitinase 3-like-1
gene product, plays an important role in acute kidney injury (AKI) and repair, but data …

Towards developing criteria for scleroderma renal crisis: a scoping review

S Hoa, EP Stern, CP Denton, M Hudson, M Baron… - Autoimmunity …, 2017 - Elsevier
Objective The absence of a gold standard for scleroderma renal crisis (SRC) has hindered
our understanding of this problem. The objective of this scoping review was to identify the …

Analysis of anti-RNA polymerase III antibody-positive systemic sclerosis and altered GPATCH2L and CTNND2 expression in scleroderma renal crisis

EP Stern, SG Guerra, H Chinque, V Acquaah… - The Journal of …, 2020 - jrheum.org
Objective Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis
(SSc) strongly associated with anti-RNA polymerase III antibody (ARA) autoantibodies. …

[HTML][HTML] Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trial

EP Stern, LV Host, I Wanjiku, KJ Escott… - Arthritis Research & …, 2022 - Springer
Background We report results from a phase II randomised placebo-controlled trial assessing
zibotentan, a highly selective endothelin receptor antagonist (ERA), in chronic kidney …

Exploring molecular pathology of chronic kidney disease in systemic sclerosis by analysis of urinary and serum proteins

EP Stern, R Unwin, A Burns, VH Ong… - … Advances in Practice, 2021 - academic.oup.com
Objective. Renal involvement is common in systemic sclerosis (scleroderma; SSc) and
includes chronic kidney disease (CKD). We have performed analysis of urinary proteins to gain …

[HTML][HTML] Management of renal involvement in scleroderma

EP Stern, VD Steen, CP Denton - Current Treatment Options in …, 2015 - Springer
Opinion statement The major renal manifestation of systemic sclerosis is scleroderma renal
crisis (SRC). This condition is characterized by accelerated phase hypertension and acute …

Scleroderma renal crisis

EP Stern, CP Denton - Scleroderma: From Pathogenesis to …, 2017 - Springer
Mrs M is a 53-year-old Caucasian nurse who was previously fit and well. Her only prior
medical history is of essential hypertension, for which she has taken ramipril 5 mg daily for 2 …

Association of predominantly peripheral lesions on ultra-widefield imaging and the risk of diabetic retinopathy worsening over time

…, ME Thomas, NM Massu, PA Edwards… - JAMA …, 2022 - jamanetwork.com
Importance Ultra-widefield (UWF) imaging improves the ability to identify peripheral diabetic
retinopathy (DR) lesions compared with standard imaging. Whether detection of …